Avidity Biosciences, Inc. (RNA) Financials
RNA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2024-03-31 | 951.5 million | 120.6 million |
| 2023-12-31 | 628.6 million | 127.8 million |
| 2023-09-30 | 573.2 million | 55.7 million |
| 2023-06-30 | 610.8 million | 51.6 million |
RNA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2024-03-31 | -71.3 million | 10.3 million |
| 2023-12-31 | 15.6 million | 9.8 million |
| 2023-09-30 | -37.7 million | 9.8 million |
| 2023-06-30 | -50.4 million | 9.5 million |
RNA Net Income
No data available :(
RNA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2024-03-31 | 915.9 million | - | - |
| 2023-12-31 | 595.4 million | - | 9.9 million |
| 2023-09-30 | 542.6 million | - | 10.6 million |
| 2023-06-30 | 576.5 million | - | 9.5 million |
RNA Shares Outstanding
RNA Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2024-03-31 | 915000 | 66.8 million | 13.9 million | -641000 |
| 2023-12-31 | 863000 | 52.8 million | 16.1 million | -615000 |
| 2023-09-30 | 923000 | 47.7 million | 13.7 million | - |
| 2023-06-30 | 622000 | 42.7 million | 12.3 million | - |
RNA Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2024-03-31 | 3.5 million | 641000 |
| 2023-12-31 | 2.2 million | 615000 |
| 2023-09-30 | 2.8 million | 1.3 million |
| 2023-06-30 | 2.3 million | 1.3 million |
RNA
Price: $29.50
52 week price:
Earnings Per Share: -2.91 USD
P/E Ratio: -4.50
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 810900
Market Capitalization: 2.5 billion